Cellebrite CLBT Q1 2026 Earnings EPS 012 Beats Estimates Lindsay Corporation LNN Gains 265 Support Holds at 10271 20260518 Fed May Need to Raise Rates in July to Appease Bond Vigilantes Yardeni Warns Canada to Review Amazon Contracts After Quebec Warehouse Closure and Layoffs Ramaco Resources METC Q1 2026 Disappoints EPS 030 Below 021 Views Adicet Bio ACET Q1 2026 Earnings EPS 188 Beats Estimates Translational Development Acquisition Corp TDAC Holds Steady Near Resistance as Trading Volume Remains Muted Reservoir Media RSVR Stalls at 1016 Consolidation Phase 20260520 Hassett Calls Record Credit Card Spending a Win as Delinquencies Rise and Farm Bankruptcies Surge 46 Julius Baer Reports SFr 528 Billion AUM Expects Substantially Higher FirstHalf Profit Micron Stock Surges Toward Best Month Since 1987 as Analysts See Further Value US Payrolls Surge Past Expectations Yet Underlying Economic Concerns Remain SpaceXs Potential SP Sector Classification Rockets Satellites and AI Integration April Jobs Report Preview Labor Market Cooling but Resilient Economists Anticipate SVM Q1 2026 Earnings Strong EPS Beat Drives Interest Amid Modest Stock Pullback DVS Q4 2025 Earnings EPS Misses Estimates Significantly as Silver Exploration Continues Turkcell Q4 2025 Earnings EPS of 440 Reported Amid Stock Pullback Bowman Consulting Group Ltd Q1 2026 Earnings Significant EPS Miss Sends Mixed Signals RSG Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Carriage Services Expands into Greater Knoxville Market with McCammon Ammons Click Funeral Home Acquisition CELH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Rockwell Medical Q1 2026 Earnings Wider Loss Stock Declines as Revenue Details Linger INTC Q1 2026 Earnings Earnings Surge on Massive EPS Beat Amidst Revenue Uncertainty SKM Q4 2025 Earnings EPS Misses Estimates Stock Declines HCWC Q4 2025 Earnings Narrow EPS Beat Masks Operational Uncertainty Shares Slip Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges CMCT Q3 2024 Earnings Massive EPS Miss Sends Stock Lower Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher